Quick answers
- What is Bloxiverz?
- Bloxiverz is a brand name of Neostigmine methylsulfate, a prescription medicine. The FDA NDC Directory lists 1 Bloxiverz product in 1 strength and form.
- Who makes Bloxiverz?
- Exela Pharma holds the FDA application for Bloxiverz (NDA204078, approved May 31, 2013).
- Is there a generic or store brand of Bloxiverz?
- Yes. The FDA NDC Directory lists 25 other products with the same active ingredients, strength and form as a Bloxiverz product, 25 of them generic. Ask your pharmacist whether one is right for you.
- Has Bloxiverz been recalled?
- No recall linked to Bloxiverz products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Bloxiverz is
Each Bloxiverz product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Neostigmine methylsulfate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| neostigmine methylsulfate 1 mg/mL injection (intravenous) | Bloxiverz | 25 products, 19 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Neostigmine methylsulfate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA204078 | Exela Pharma | May 31, 2013 | 1 |
Companies that list Bloxiverz
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Bloxiverz products.
- Exela Pharma Sciences, LLC1 product
Recalls
No recall linked to Bloxiverz products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.